Last reviewed: June 18, 2026
Last updated: June 18, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide therapy typically begins with a 0.25 mg weekly injection, yet many patients receive 1 mg pens that require precise measuring. Understanding how to extract and inject the correct starting dose is essential for treatment success and minimizing gastrointestinal side effects during the critical first month of therapy.
Why Semaglutide Treatment Starts at 0.25 mg
The 0.25 mg initial dose serves as a titration step designed to allow your body to acclimate to GLP-1 receptor activation. Clinical trials demonstrate that patients tolerate this lower starting dose significantly better than jumping to higher amounts, reducing nausea and other adjustment-related side effects. Beginning with this foundational dose establishes a safety baseline before advancing to therapeutic concentrations.
Your gastrointestinal system needs time to adapt to semaglutide's appetite-suppressing mechanisms. The first four weeks at 0.25 mg help your stomach sensitivity adjust while your body begins responding to the medication. This gradual approach also allows your prescriber to monitor how well you tolerate the compound before increasing your dose.
How to Accurately Measure 0.25 mg from a 1 mg Pen
A 1 mg pen contains four equal doses of 0.25 mg each, making mathematical measurement straightforward but technique-dependent. The pen's dial mechanism typically marks quarter-turn increments, and your instructions should specify the exact number of units to dial before injection. Always verify your specific pen's measurement markings match your prescribed dose, as pen designs vary by manufacturer.
Before attempting your first injection, inspect the pen's dial closely and practice the clicking action without pressing the plunger. Some pens use numerical dials showing 0.25, 0.50, 0.75, and 1.0 mg markings, while others require counting clicks. Check your pen's package insert or ask your pharmacist to confirm your particular model's measuring method, since misreading the dial is the most common dosing error.
Step-by-Step Injection Technique for Semaglutide
Begin by washing your hands thoroughly and selecting an injection site on your abdomen, outer thigh, or upper arm—areas with subcutaneous fat tissue. Pinch the skin gently at your chosen site and insert the needle at a 90-degree angle. Press the plunger slowly and steadily, holding the needle in place for three seconds after you feel the click indicating dose delivery, then withdraw at the same 90-degree angle.
Proper site rotation prevents lipohypertrophy, a condition where repeated injections in the same location create fatty deposits that reduce medication absorption. Maintain at least one inch of distance between each week's injection site within the same body region. After injection, place the used needle in a designated sharps container—never dispose of needles in regular household trash—and mark the date on your pen to track when it was first opened.
PlexusDx Semaglutide Therapy: Dosing Without Price Increases
PlexusDx delivers compounded semaglutide injections from licensed 503A pharmacies starting at $149 per month, with pricing that remains flat regardless of dose escalation. Many patients begin at 0.25 mg weekly and progress through standard titration steps—0.50 mg, 0.75 mg, and 1.0 mg—without facing higher monthly bills. This transparent pricing model removes the financial barrier that sometimes prevents patients from advancing to their optimal therapeutic dose.
PlexusDx serves all 50 states without requiring insurance coverage or membership fees, making precision weight loss therapy accessible to more patients. Your Precision Peptide Genetic Test identifies individual variations in GLP-1 receptor sensitivity and peptide metabolism pathways, helping your prescriber predict how your body will respond to dose escalation. HSA and FSA accounts are accepted, further reducing your out-of-pocket treatment costs.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I start at 0.25 mg semaglutide if I'm nervous about injections?
Yes—the lower starting dose means fewer systemic effects, making it an ideal entry point for injection-anxious patients. PlexusDx offers both injection and oral semaglutide options if needle anxiety is significant. Speaking with your prescriber about your concerns allows them to provide reassurance and detailed technique coaching before your first dose.
How long do I stay at the 0.25 mg dose before moving up?
Standard dosing protocols maintain 0.25 mg for four weeks to allow tolerance development, then escalate by 0.25 mg increments weekly until reaching your target dose or experiencing adequate weight loss. Clinical evidence shows this gradual titration improves long-term adherence by reducing the severity of initial nausea. Your PlexusDx prescriber will adjust timing based on your individual tolerance and response.
What if I accidentally dial the wrong dose on my pen?
Do not use the pen if you cannot clearly see the correct dial marking. Contact your PlexusDx pharmacy or prescriber immediately—they can provide guidance on dose correction or dispensing replacement medication. Never attempt to estimate a dose or use a partially-delivered pen without professional confirmation of the actual injected amount.
Are compounded semaglutide injections as safe as brand-name Ozempic®?
PlexusDx sources semaglutide from licensed 503A compounding pharmacies that follow FDA manufacturing standards for purity, potency, and sterility. While compounded medications are not FDA-approved as finished products, the active pharmaceutical ingredient is identical to brand formulations, and quality controls remain stringent. Your prescriber and pharmacist monitor your response closely to ensure safety throughout your treatment.
How does the Precision Peptide Genetic Test predict my semaglutide response?
PlexusDx's Precision Peptide Genetic Test ($99 after your first month) analyzes 14 metabolic pathways including your GLP-1 receptor genetic variants. Key genetic markers like GLP1R rs6923761 influence how sensitively your appetite centers respond to semaglutide, predicting whether you'll need lower or higher doses for optimal results. This personalization helps your prescriber establish your ideal maintenance dose faster while minimizing side effects.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Weight Loss with Wegovy and a Hiatal Hernia: Your Path to Health
Navigating Ozempic Prior Authorization: How Long Does It Really Take?